Aquestive Therapeutics Inc
Aquestive Therapeutics Inc (AQST) Option Chain
Read more
Tracking the AQST option chain helps you see every strike and expiry on Aquestive Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of AQST options activity at a glance. Use our scanner to monitor the AQST option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For AQST stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where AQST options are being actively traded, and where they are not.
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.00 | 0 | 0 | 0.14 | 2.46 | 0.60 | 4.60 | 1.00 | -71.10 | — | 0.20 | 0.00 | 0.20 | 0 | 0 | 100.00 |
| 5.00 | 6 | 0 | -0.06 | 1.46 | 0.90 | 1.90 | 2.00 | -42.20 | — | 0.05 | 0.00 | 0.05 | 0 | 21,433 | 95.00 |
| 37.37 | 292 | 0 | 0.32 | 0.46 | 0.45 | 1.10 | 3.00 | -13.29 | — | 0.10 | 0.00 | 0.10 | 25 | 31 | 62.63 |
| 73.11 | 165 | 17 | 0.15 | 0.00 | — | 0.15 | 4.00 | +15.61 | 0.55 | 1.00 | 0.54 | 0.24 | 257 | 7,611 | 26.90 |
| 91.05 | 137 | 10 | 0.40 | 0.00 | — | 0.40 | 5.00 | +44.51 | 1.00 | 2.00 | 1.54 | -0.04 | 0 | 2 | 8.95 |
As of Nov 20, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV Rank75.00% High
- Market cap (M$)435
- 52 weeks high-48.66%
- 52 weeks low18.09%
- Analyst recommendationStrong Buy
1.00 - Target price$9.33
169.65% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-03
- P/E—
- Future P/E—
- EPS (ttm)-0.64
- EPS growth next 5 years22.72%
As of Nov 20, 2026